Literature DB >> 18802144

High-dose methotrexate in osteosarcoma: let the questions surcease--time for final acceptance.

Norman Jaffe1, Richard Gorlick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18802144     DOI： 10.1200/JCO.2007.14.7793

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  26 in total

Review 1.  Pharmacokinetic Properties of Anticancer Agents for the Treatment of Central Nervous System Tumors: Update of the Literature.

Authors:  Megan O Jacus; Vinay M Daryani; K Elaine Harstead; Yogesh T Patel; Stacy L Throm; Clinton F Stewart
Journal:  Clin Pharmacokinet       Date:  2016-03       Impact factor: 6.447

Review 2.  Methotrexate for high-grade osteosarcoma in children and young adults.

Authors:  Elvira C van Dalen; Jorrit W van As; Beatriz de Camargo
Journal:  Cochrane Database Syst Rev       Date:  2011-05-11

3.  Determination of Methotrexate, 7-Hydroxymethotrexate, and 2,4-Diamino-N10-methylpteroic Acid by LC-MS/MS in Plasma and Cerebrospinal Fluid and Application in a Pharmacokinetic Analysis of High-Dose Methotrexate.

Authors:  Michael S Roberts; Nicholas S Selvo; Jessica K Roberts; Vinay M Daryani; Thandranese S Owens; K Elaine Harstead; Amar Gajjar; Clinton F Stewart
Journal:  J Liq Chromatogr Relat Technol       Date:  2016-10-10       Impact factor: 1.312

4.  Hypersensitivity reaction to high-dose methotrexate and successful rechallenge in a pediatric patient with osteosarcoma.

Authors:  Jeffrey R Scott; Deborah A Ward; Kristine R Crews; John C Panetta; Fariba Navid
Journal:  Pediatr Blood Cancer       Date:  2013-08-19       Impact factor: 3.167

5.  Bioluminescent sensor proteins for point-of-care therapeutic drug monitoring.

Authors:  Rudolf Griss; Alberto Schena; Luc Reymond; Luc Patiny; Dominique Werner; Christine E Tinberg; David Baker; Kai Johnsson
Journal:  Nat Chem Biol       Date:  2014-06-08       Impact factor: 15.040

6.  What are the factors that affect survival and relapse after local recurrence of osteosarcoma?

Authors:  Akihiko Takeuchi; Valerae O Lewis; Robert L Satcher; Bryan S Moon; Patrick P Lin
Journal:  Clin Orthop Relat Res       Date:  2014-07-01       Impact factor: 4.176

7.  Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects.

Authors:  Lisa R Treviño; Noriko Shimasaki; Wenjian Yang; John C Panetta; Cheng Cheng; Deqing Pei; Diana Chan; Alex Sparreboom; Kathleen M Giacomini; Ching-Hon Pui; William E Evans; Mary V Relling
Journal:  J Clin Oncol       Date:  2009-11-09       Impact factor: 44.544

8.  Role of methamphetamine on glioblastoma cytotoxicity induced by doxorubicin and methotrexate.

Authors:  Tânia Capelôa; Francisco Caramelo; Carlos Fontes-Ribeiro; Célia Gomes; Ana P Silva
Journal:  Neurotox Res       Date:  2014-03-21       Impact factor: 3.911

9.  Acute renal failure post high dose methotrexate infusion successfully managed with high dose folinic Acid and high flux dialysis.

Authors:  Suthanthira Kannan Ramamoorthy; R Hephziba
Journal:  Indian J Hematol Blood Transfus       Date:  2012-01-11       Impact factor: 0.900

Review 10.  Osteosarcoma: Current Treatment and a Collaborative Pathway to Success.

Authors:  Michael S Isakoff; Stefan S Bielack; Paul Meltzer; Richard Gorlick
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.